For pathology providers: Supporting cervical screening participants
Pathology laboratories play a vital role in delivering high-quality cervical screening services and supporting the health outcomes of participants.
Through the National Cancer Screening Register (NCSR), laboratories can:
- request and view participant screening histories
- submit pathology results for human papillomavirus (HPV) and Liquid-Based Cytology (LBC) tests
Benchmarking HPV positivity rates
One of the key quality assurance measures in the National Cervical Screening Program (NCSP) is the regular monitoring of HPV positivity rates by pathology laboratories.
Laboratories are expected to assess and benchmark their HPV detection rates against national averages to support continuous improvement in screening performance and accuracy.
National Cervical Screening Program guidelines
The NCSP Guidelines support best practice in the management of screen-detected abnormalities, screening for specific populations, and the investigation of abnormal vaginal bleeding.
The guidelines have been updated to reflect current evidence and clinical practice, with changes taking effect from April 2025.